content top

Intravitreal Bevacizumab as Isolated First Line Therapy in Patients with New Untreated Choroidal Neovascular Membranes

http://www.evrs.eu/medias/2006/congress/Intravitreal-Bevacizumab-as-Isolated-First-Line-Therapy-in-Patients-with-New-Untreated-Choroidal-Neovascular-Membranes.swf Alay S Banker, MD (Ahmedabad, India), Marisa Flores-Aguilar, MD (Tijuana, Mexico), J. Fernando Arevalo, MD, FACS (Caracas, Venezuela) PURPOSE: To determine results of intravitreal bevacizumab in patients with choroidal neovascular membranes (CNVMs) of different types and...

Read More

Use of Trypan Blue Dye in Removal of Internal Limiting Membrane (ILM)

http://www.evrs.eu/medias/2006/videos/Use-of-Trypan-Blue-Dye-in-Removal-of-Internal-Limiting-%20Membrane-(ILM).flv Alay S. Banker, MD (Ahmedabad, India), Marisa Flores-Aguilar, MD (Tijuana, Mexico) SYNOPSIS The video demonstrates the efficacy of (0.2%) trypan blue dye for staining internal limiting membrane (ILM) in eyes undergoing vitrectomy for macular hole, vitreomacular traction syndrome and diabetic retinopathy. Trypan blue resulted in...

Read More
content top